These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: THE PREVALENCE OF COVID-19 IN THE COUNTRIES OF THE GULF COOPERATION COUNCIL: AN EXAMINATION AFTER THREE YEARS.
    Author: Alrasheedi A.
    Journal: Georgian Med News; 2023 Feb; (335):6-12. PubMed ID: 37042580.
    Abstract:
    The coronavirus disease (COVID-19) pandemic in the Gulf Cooperation Council (GCC) countries is part of the global pandemic. So, the current study used COVID-19 statistics to examine the COVID-19 prevalence in the GCC countries by the end of 2020, 2021, and 2022 and compare the findings to non-GCC Arab countries and also compare 2022's results globally. COVID-19 data per country, including the vaccination coverage rate, were obtained from well-known publicly online websites (such as Worldometer and Our World in Data). An Independent sample t-test was used to compare the means between the GCC and non-GCC Arab countries. By the end of 2022, most COVID-19 deaths in the GCC countries were recorded in Saudi Arabia but given the number of cases and deaths per million, Bahrain was the most affected. Saudi Arabia was the least testing country per population, while the United Arab of Emirates performed tests nearly 20 times more than its population. Qatar had the lowest case-fatality rate (0.14%). Statistically, the GCC countries had higher median age, higher mean cases per million, higher mean tests per population, and higher mean vaccination coverage (84.56%) than non-GCC Arab countries. Globally, the GCC countries recorded fewer deaths per million, performed more tests relative to the population, and had higher vaccination coverage. Globally, the GCC countries have been less affected by the COVID-19 pandemic. However, statistics vary across the GCC countries. The average vaccination coverage in the Gulf countries was higher than in the global one. Given the natural immunity and the excellent vaccine coverage in the GCC countries, it is essential to reconsider the definition of a suspected case and establish more specific criteria for testing.
    [Abstract] [Full Text] [Related] [New Search]